Based on the cutting edge technologies for biomarker discovery, we are aiming at personalized medicine as a theragnostics company.
-
Introduction of the advanced sample preparation technology for future diagnostics
- Noninvasive: CTC (circulating tumor cells) detection
- High-precision: LCM (laser micro-dissection)
-
Contents development for future diagnostics
- HPV, Toxoplasma detection
-
IVD development
- Application for approval is under contemplation
- Seeking partnership with an IVD company
